Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies

被引：0
|
作者：
Pishoy Gouda
Sijia Zheng
Tricia Peters
Marat Fudim
Varinder Kaur Randhawa
Justin Ezekowitz
Thomas A. Mavrakanas
Nadia Giannetti
Michael Tsoukas
Renato Lopes
Abhinav Sharma
机构：
[1] University of Alberta,Department of Medicine, Division of Cardiology
[2] McGill University Health Centre,Department of Medicine
[3] Lady Davis Institute for Medical Research,Centre for Clinical Epidemiology
[4] The Jewish General Hospital,Division of Endocrinology, Department of Medicine
[5] McGill University,Department of Medicine, Duke Clinical Research Institute
[6] Duke University Medical Center,Department of Cardiovascular Medicine, Kaufman Center for Heart Failure and Recovery
[7] Cleveland Clinic Foundation,Division of Nephrology, Department of Medicine
[8] Canadian VIGOUR Centre,Division of Endocrinology
[9] McGill University Health Centre and Research Institute,undefined
[10] McGill University Health Centre,undefined
来源：
Current Heart Failure Reports | 2021年 / 18卷
关键词：
Diabetes; Phenotypes; Cardiovascular outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 263
页数：10
相关论文
共 50 条
  • [1] Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies
    Gouda, Pishoy
    Zheng, Sijia
    Peters, Tricia
    Fudim, Marat
    Randhawa, Varinder Kaur
    Ezekowitz, Justin
    Mavrakanas, Thomas A.
    Giannetti, Nadia
    Tsoukas, Michael
    Lopes, Renato
    Sharma, Abhinav
    CURRENT HEART FAILURE REPORTS, 2021, 18 (05) : 253 - 263
  • [2] Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Braunwald, Eugene
    Steg, P. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Ohman, Peter
    Frederich, Robert
    Wiviott, Stephen D.
    Hoffman, Elaine B.
    Cavender, Matthew A.
    Udell, Jacob A.
    Desai, Nihar R.
    Mosenzon, Ofri
    McGuire, Darren K.
    Ray, Kausik K.
    Leiter, Lawrence A.
    Raz, Itamar
    Braunwald, Eugene
    Bhatt, Deepak L.
    Scirica, Benjamin M.
    Udell, Jacob A.
    Cavender, Matthew A.
    Desai, Nihar
    Abrahamsen, Timothy
    Grossman, Michelle
    Morin, Suzanne
    Im, Kyungah
    Hoffman, Elaine
    Gabovitch, Daniel
    Pricken, Alexandra
    Mosenzon, Ofri
    Buskila, Alona
    Ohman, Peter
    Hirshberg, Boaz
    Stahre, Christina
    Price, Deborah
    Billing-Clason, Solveig
    Sabel, Karin
    Monyak, John
    Sjostrand, Mikalea
    Wei, Cheryl
    Lu, Jane
    Miller, Elinor
    Raichlen, Joel
    Fitt, Sandy
    Frederich, Robert
    Iqbal, Nayyar
    Donovan, Mark
    Davidson, Jaime A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1317 - 1326
  • [3] CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
    Sapozhnikova, I. E.
    Tarlovskaya, E. I.
    Anufrieva, E. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (03) : 8 - 13
  • [4] Clinical characteristics associated with the presence of echocardiographic phenotypes of heart failure in patients with type 2 diabetes mellitus
    Yeshniyazov, N. Nurlan
    Medovchshikov, V. V.
    Bayarsaikhan, M.
    Khasanova, E. R.
    Gudieva, K. M.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 324 - 324
  • [5] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [6] Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2
    Osipenko, M. F.
    Zhuk, E. A.
    Medvedeva, O. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (02) : 43 - 47
  • [7] Evaluation and Review of Strategies to Assess Cardiovascular Risk in Clinical Trials in Patients with Type 2 Diabetes Mellitus
    Marchenko, Olga
    Jiang, Qi
    Chakravarty, Aloka
    Ke, Chunlei
    Ma, Haijun
    Maca, Jeff
    Russek-Cohen, Estelle
    Sanchez-Kam, Matilde
    Zink, Richard C.
    Chuang-Stein, Christy
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (04): : 253 - 266
  • [8] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [9] Impact of type 2 diabetes mellitus on clinical outcomes in patients with COVID-19 and cardiovascular disease
    Lobanova, K. G.
    Demidova, T. Y. U.
    Plakhotnyaya, V. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2625 - 2625
  • [10] Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus
    Kapoor, Karan
    George, Praveen
    Miller, Michael
    CARDIOLOGY, 2016, 135 (02) : 108 - 126
12345